000 01169 a2200325 4500
005 20250515070910.0
264 0 _c20071026
008 200710s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/j.transproceed.2007.03.049
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFiller, G
245 0 0 _aOptimization of immunosuppressive drug monitoring in children.
_h[electronic resource]
260 _bTransplantation proceedings
_cMay 2007
300 _a1241-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAge Factors
650 0 4 _aChild
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCyclosporine
_xpharmacokinetics
650 0 4 _aDrug Interactions
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xpharmacokinetics
650 0 4 _aMycophenolic Acid
_xpharmacokinetics
650 0 4 _aSirolimus
_xpharmacokinetics
650 0 4 _aTacrolimus
_xpharmacokinetics
773 0 _tTransplantation proceedings
_gvol. 39
_gno. 4
_gp. 1241-3
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2007.03.049
_zAvailable from publisher's website
999 _c17068363
_d17068363